Showing results (151-160 of 194) with videos related to
Sort By:
Pageof 20
The New England Journal of Medicine|May 16, 2008
Class-sparing regimens for initial treatment of HIV-1 infectionSharon A Riddler, Richard Haubrich, A Gregory DiRienzo, et al.American Journal of Respiratory and Critical Care Medicine|August 17, 2021
A Semimechanistic Model of the Bactericidal Activity of High-Dose Isoniazid against Multidrug-Resistant Tuberculosis: Results from a Randomized Clinical TrialKamunkhwala Gausi, Elisa H Ignatius, Xin Sun, et al.The Journal of Antimicrobial Chemotherapy|June 9, 2022
Pharmacokinetics of standard versus high-dose isoniazid for treatment of multidrug-resistant tuberculosisKamunkhwala Gausi, Maxwell Chirehwa, Elisa H Ignatius, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2021
Resistance to Mycobacterium tuberculosis Infection Among Household Contacts: A Multinational StudyDavit Baliashvili, Neel R Gandhi, Soyeon Kim, et al.Open Forum Infectious Diseases|January 5, 2026
Monocyte Activation in People With HIV and Tuberculosis Coinfection and Effect of Tuberculosis Preventive Therapy: An Analysis of the ACTG A5279/BRIEF TB TrialMoises A Huaman, Manuel G Feria, Michelle A Kendall, et al.BMC Infectious Diseases|February 25, 2021
Drug susceptibility patterns of Mycobacterium tuberculosis from adults with multidrug-resistant tuberculosis and implications for a household contact preventive therapy trialAnne-Marie Demers, Soyeon Kim, Sara McCallum, et al.Journal of Viral Hepatitis|March 28, 2024
Preferences and feasibility of long-acting technologies for treatment of hepatitis C virus in low- and middle-income countries: A survey of providers and policymakersNeil Gupta, Susan Swindells, Kimberly K Scarsi, et al.Pharmacogenetics and Genomics|June 12, 2023
Pharmacogenetic interactions of efavirenz or rifampin and isoniazid with levonorgestrel emergency contraception during treatment of HIV or tuberculosisNana Agyemang, Kimberly K Scarsi, Paxton Baker, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 26, 2021
Preferences of Persons With or at Risk for Hepatitis C for Long-Acting TreatmentsEthel D Weld, Jacqueline Astemborski, Gregory D Kirk, et al.Neuroimage|November 6, 2004
Regional patterns of brain metabolites in AIDS dementia complexConstantin T Yiannoutsos, Thomas Ernst, Linda Chang, et al.Pageof 20